These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 2850408)
1. [Biological significance of estrogen receptor status in axillary lymph node metastases of invasive ductal breast cancers]. Horst HA; Horny HP; Gent HJ; Sellschopp C; Hedderich J Klin Wochenschr; 1988 Dec; 66(23):1160-6. PubMed ID: 2850408 [TBL] [Abstract][Full Text] [Related]
2. Primary tumour characteristics and axillary lymph node status in breast cancer. Yiangou C; Shousha S; Sinnett HD Br J Cancer; 1999 Aug; 80(12):1974-8. PubMed ID: 10471048 [TBL] [Abstract][Full Text] [Related]
3. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664 [TBL] [Abstract][Full Text] [Related]
4. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases]. Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002 [TBL] [Abstract][Full Text] [Related]
5. [Comparison of the receptor content and growth fraction of breast cancers and their axillary lymph node metastases]. Fleige B; Pickartz H; Stein H Pathologe; 1989 Jan; 10(1):12-5. PubMed ID: 2646629 [No Abstract] [Full Text] [Related]
6. Breast cancer primary tumor ER expression pattern predicts its expression concordance in matched synchronous lymph node metastases. Zhao J; Hu C; Wang C; Yu W; Guo Y; Shi M; Shui Y; Wei Q BMC Cancer; 2018 Dec; 18(1):1290. PubMed ID: 30587150 [TBL] [Abstract][Full Text] [Related]
7. Biomarker expression and St Gallen molecular subtype classification in primary tumours, synchronous lymph node metastases and asynchronous relapses in primary breast cancer patients with 10 years' follow-up. Falck AK; Bendahl PO; Chebil G; Olsson H; Fernö M; Rydén L Breast Cancer Res Treat; 2013 Jul; 140(1):93-104. PubMed ID: 23807420 [TBL] [Abstract][Full Text] [Related]
8. [Cathepsin D in primary breast cancer in correlation with various prognostic factors]. Rempen A; Caffier H Geburtshilfe Frauenheilkd; 1991 Apr; 51(4):272-5. PubMed ID: 1650323 [TBL] [Abstract][Full Text] [Related]
9. Improved detection of metastases to lymph nodes and estrogen receptor determination. Schurman SH; Sharon N; Goldschmidt RA; Scanlon EF Arch Surg; 1990 Feb; 125(2):179-82. PubMed ID: 1689142 [TBL] [Abstract][Full Text] [Related]
10. [Proliferation index, axillary lymph node status, hormone receptors and age as prognostic factors in primary breast cancer]. Kaufmann M; Klinga K; Kühn W; Abel U Geburtshilfe Frauenheilkd; 1989 Feb; 49 Suppl 1():104-8. PubMed ID: 2703135 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical study of estrogen receptors in primary breast carcinomas and their lymph node metastases including comparison of two monoclonal antibodies. Nedergaard L; Haerslev T; Jacobsen GK APMIS; 1995 Jan; 103(1):20-4. PubMed ID: 7695887 [TBL] [Abstract][Full Text] [Related]
12. Axillary lymph node status of operable breast cancers by combined steroid receptor and HER-2 status: triple positive tumours are more likely lymph node positive. Van Calster B; Vanden Bempt I; Drijkoningen M; Pochet N; Cheng J; Van Huffel S; Hendrickx W; Decock J; Huang HJ; Leunen K; Amant F; Berteloot P; Paridaens R; Wildiers H; Van Limbergen E; Weltens C; Timmerman D; Van Gorp T; Smeets A; Van den Bogaert W; Vergote I; Christiaens MR; Neven P Breast Cancer Res Treat; 2009 Jan; 113(1):181-7. PubMed ID: 18264760 [TBL] [Abstract][Full Text] [Related]
13. Morphologic spectrum of estrogen receptor-negative breast carcinoma. Scawn R; Shousha S Arch Pathol Lab Med; 2002 Mar; 126(3):325-30. PubMed ID: 11860308 [TBL] [Abstract][Full Text] [Related]
14. Expression of glycodelin protein and mRNA in human ductal breast cancer carcinoma in situ, invasive ductal carcinomas, their lymph node and distant metastases, and ductal carcinomas with recurrence. Jeschke U; Mylonas I; Kunert-Keil C; Dazert E; Shabani N; Werling M; Kuhn C; Janni W; Gerber B; Friese K Oncol Rep; 2005 Mar; 13(3):413-9. PubMed ID: 15706409 [TBL] [Abstract][Full Text] [Related]
15. [Estrogen and progesterone receptors of primary breast carcinoma and their axillary lymph node metastases--immunohistochemical investigations of routine formalin-fixed paraffin-embedded tissue]. Schulze MH; Buchmann J Zentralbl Gynakol; 2000; 122(2):92-5. PubMed ID: 10721188 [TBL] [Abstract][Full Text] [Related]
16. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [TBL] [Abstract][Full Text] [Related]
17. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases. Briffod M; Hacène K; Le Doussal V Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449 [TBL] [Abstract][Full Text] [Related]
18. Alterations in hormonal receptor expression and HER2 status between primary breast tumors and paired nodal metastases: discordance rates and prognosis. Ba JL; Liu CG; Jin F Asian Pac J Cancer Prev; 2014; 15(21):9233-9. PubMed ID: 25422206 [TBL] [Abstract][Full Text] [Related]
19. Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study. Bezić J; Samija-Projić I; Projić P; Ljubković J; Capkun V; Tomić S Pathol Res Pract; 2011 Jul; 207(7):438-42. PubMed ID: 21689895 [TBL] [Abstract][Full Text] [Related]
20. Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Noguchi M; Ohta N; Koyasaki N; Taniya T; Miyazaki I; Mizukami Y Cancer; 1991 Nov; 68(9):1918-25. PubMed ID: 1655229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]